TerrAscend (TSNDF) Revenue Growth (1y) (2022 - 2026)
TerrAscend (TSNDF) Revenue Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | 2.34% |
| 3 | Zoetis | 32.57 Bn | 30.63 Bn | 1.62 Bn | 2.91% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -11.85% |
| 5 | United Therapeutics | 23.06 Bn | 20.90 Bn | 648.10 Mn | -1.62% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.43 Bn | 18.62 Bn | 1.16 Bn | 7.85% |
| 8 | Neurocrine Biosciences | 17.81 Bn | 16.49 Bn | 800.70 Mn | 42.25% |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | 14.92% |
| 10 | TerrAscend | 168.49 Mn | 168.02 Mn | 34.60 Mn | 1.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.92% |
| Dec 31, 2025 | -0.45% |
| Sep 30, 2025 | -0.09% |
| Jun 30, 2025 | -3.26% |
| Mar 31, 2025 | -20.25% |
| Dec 31, 2024 | 236.49% |
| Sep 30, 2024 | -26.98% |
| Jun 30, 2024 | -6.83% |
| Mar 31, 2024 | 16.19% |
| Dec 31, 2023 | -70.95% |
| Sep 30, 2023 | 34.72% |
| Jun 30, 2023 | 12.31% |
| Mar 31, 2023 | 41.46% |
| Dec 31, 2022 | 169.77% |
| Sep 30, 2022 | 34.81% |
| Jun 30, 2022 | 3.62% |
| Mar 31, 2022 | -8.05% |